ºìÐÓÖ±²¥app requires that research or educational activities that use recombinant DNA technology or potentially infectious agents be reviewed and approved by an Institutional Biosafety Committee (IBC) to ensure that they are conducted in a safe and appropriate manner, and in accordance with federal regulations and guidelines published by NIH, CDC, OSHA and other funding and/or regulatory agencies.
Email the chair for more information about Dickinson's Biosafety Committee.
Some portions of this web site are restricted to the users or groups within the Dickinson community. If you are logged in and still cannot view the content, this page may be restricted to a specific group due to privacy or copyright concerns.